medigraphic.com

1999, Number 6

<< Back

Enf Infec Microbiol 1999; 19 (6)

Community acquired pneumonia. Diagnostic elements, severity assessment. Management and prevention guidelines

Soto HJL, Hermida EC, Ponce De León RS, Rangel FS, Reyes TG, Rivera BC, Sada DE, Jáuregui CA, Jiménez E, Lazo VS, Macías HA, Molina GJ, Ramírez RM, Rodríguez NE

Language: Spanish
References: 14
Page: 301-316
PDF size: 92.64 Kb.


Text Extraction

No abstract


REFERENCES

  1. Syrjälä H, Broas M, Suramo I, Ojala A, Lähde S. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 1998;27:358-63.

  2. Chodosh S. Examination of sputum cells. New Engl J Med 1970; 282:854-7.

  3. Murray PR, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clinic Proc 1975;50:339-44.

  4. Wong LK, Barry AL, Gorgan S. Comparison of six different criteria for judging the acceptability of sputum specimens. J Clin Microbiol 1982;16:627-31.

  5. Rein MF, Gwaltney, O’Brien W, Jennings RH, Mandell GL. Accuracy of Gram’s stain in identifying pneumococci in sputum. JAMA 1978;239:2671-3.

  6. Ponce de León RS, Rangel S. Nuevas técnicas de aislamiento. Enf Infec y Microbiol 1996;16:23-28.

  7. Sánchez MG, Calva JJ, Ponce de León S, Sifuentes OJ, Ojeda RF. Utilidad y riesgos del aspirado transtraqueal en el diagnóstico de infecciones pulmonares. Rev Invest Clin 1991;43:285-92.

  8. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community acquired pneumonia. N Engl J Med 1997;336:243-50.

  9. Mandell LA. Advances in antimicrobial therapy of community acquired pneumonia. Curr Opin Infect Dis 1999;12:137-43.

  10. Baquero F. Antibiotic resistance in Spain: What can be done? Clin Infect Dis 1996;23:819-23.

  11. Orrantia GRD, Silva O, Pontani DR y el Grupo de estudio Artemis para América Latina. El proyecto Artemis. Un estudio sobre la actividad de algunos antibióticos de uso común para el tratamiento de las infecciones del tracto respiratorio en diez países latinoamericanos. Rev Panam Infectol 1998;2:68-75.

  12. Marrie TJ. Management decision regarding community-acquired pneumonia. Curr Opin Infect Dis 1999;12:133-6.

  13. Halm EH, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with communityacquired pneumonia. JAMA 1998;279:1452-7.

  14. Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: A review focusing on newer agents. Clin Infect Dis 1999;28:352-64.




2020     |     www.medigraphic.com